產(chǎn)品中心
標(biāo)記一抗
英(yīng)文名稱Anti-ATG4A/FITC
中(zhōng)文(wén)名稱(chēng):FITC標(biāo)記的自噬(shì)相關(guān)蛋白4A抗體(tǐ)
別 名(míng)ATG4A is a cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.
規(guī)格:100ul
說(shuō) 明(míng) 書100ul
研(yán)究領域(yù)腫瘤(liú) 免疫學(xué) 細(xì)胞凋(diāo)亡(wáng) 轉錄調節因子(zǐ)
抗體(tǐ)來(lái)源Rabbit
克(kè)隆類(lèi)型Polyclonal
交叉(chā)反應(yīng) Human, Mouse, Rat, Cow, Rabbit,
產品應用IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分(fēn) 子 量(liáng)45kDa
性 狀Lyophilized or Liquid
濃 度1mg/ml
免(miǎn) 疫 原KLH conjugated synthetic peptide derived from human ATG4A
亞(yà) 型(xíng)IgG
純化(huà)方法affinity purified by Protein A
儲(chǔ) 存 液(yè)0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保(bǎo)存條件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
產(chǎn)品(pǐn)介紹background:
ATG4A is a cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.
中(zhōng)文(wén)名稱(chēng):FITC標(biāo)記的自噬(shì)相關(guān)蛋白4A抗體(tǐ)
別 名(míng)ATG4A is a cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.
詳細(xì)介(jiè)紹(shào)：
規(guī)格:100ul
說(shuō) 明(míng) 書100ul
研(yán)究領域(yù)腫瘤(liú) 免疫學(xué) 細(xì)胞凋(diāo)亡(wáng) 轉錄調節因子(zǐ)
抗體(tǐ)來(lái)源Rabbit
克(kè)隆類(lèi)型Polyclonal
交叉(chā)反應(yīng) Human, Mouse, Rat, Cow, Rabbit,
產品應用IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分(fēn) 子 量(liáng)45kDa
性 狀Lyophilized or Liquid
濃 度1mg/ml
免(miǎn) 疫 原KLH conjugated synthetic peptide derived from human ATG4A
亞(yà) 型(xíng)IgG
純化(huà)方法affinity purified by Protein A
儲(chǔ) 存 液(yè)0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保(bǎo)存條件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
相關資料(liào)：
產(chǎn)品(pǐn)介紹background:
ATG4A is a cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.
- 上一(yī)條：FITC標記(jì)的(dí)自(zì)噬相(xiāng)關蛋白18抗(kàng)體(tǐ)
- 下(xià)一(yī)條(tiáo)：FITC標記(jì)的(dí)12脂氧合酶抗(kàng)體
